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Abstract
Background: Examining geographic variation in cancer patient survival can help identify important
prognostic factors that are linked by geography and generate hypotheses about the underlying
causes of survival disparities. In this study, we apply a recently developed spatial scan statistic
method, designed for time-to-event data, to determine whether colorectal cancer (CRC) patient
survival varies by place of residence after adjusting survival times for several prognostic factors.
Methods: Using data from a population-based, statewide cancer registry, we examined a cohort
of 25,040 men and women from New Jersey who were newly diagnosed with local or regional stage
colorectal cancer from 1996 through 2003 and followed to the end of 2006. Survival times were
adjusted for significant prognostic factors (sex, age, stage at diagnosis, race/ethnicity and census
tract socioeconomic deprivation) and evaluated using a spatial scan statistic to identify places where
CRC survival was significantly longer or shorter than the statewide experience.
Results: Age, sex and stage adjusted survival times revealed several areas in the northern part of
the state where CRC survival was significantly different than expected. The shortest and longest
survival areas had an adjusted 5-year survival rate of 73.1% (95% CI 71.5, 74.9) and 88.3% (95% CI
85.4, 91.3) respectively, compared with the state average of 80.0% (95% CI 79.4, 80.5). Analysis of
survival times adjusted for age, sex and stage as well as race/ethnicity and area socioeconomic
deprivation attenuated the risk of death from CRC in several areas, but survival disparities
persisted.
Conclusion: The results suggest that in areas where additional adjustments for race/ethnicity and
area socioeconomic deprivation changed the geographic survival patterns and reduced the risk of
death from CRC, the adjustment factors may be contributing causes of the disparities. Further
studies should focus on specific and modifiable individual and neighborhood factors in the high risk
areas that may affect a person's chance of surviving cancer.
Background
In the past several years, there has been significant
progress in reducing colorectal cancer (CRC) incidence
and mortality rates in most US population groups [1].
Despite this progress, an unequal cancer burden is borne
by blacks, relative to whites, and by individuals of lower
socioeconomic position. These groups have higher inci-
dence and mortality rates, lower survival rates, and greater
percentages diagnosed at advanced stage [2,3]. Differ-
ences in CRC survival have been consistently observed in
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these groups even after adjusting for stage at diagnosis, a
significant prognostic factor [4,5]. Survival disparities
have been attributed to differences in individual and area-
based socioeconomic factors, differences in access to and
receipt of quality treatment, and post treatment follow-
up, [3,6-9], and/or from differences in comorbidity [4].
Geographic disparities in survival have also been observed
in several international and US studies for several cancer
sites including colorectal cancer [10-23]. Knowing
whether cancer survival varies geographically is especially
relevant since area-based physical, social and behavioral
factors can assist or impede patient survival. It is also rel-
evant because health care is often delivered locally, and,
therefore, the identification of areas with significantly bet-
ter or worse survival outcomes may, for example, reflect
access to and quality of care. Some factors offered as
potential explanations for geographic variation in survival
include regional or local distributions of patient charac-
teristics, (race/ethnicity) tumor characteristics (stage),
modifiable lifestyle factors (smoking, diet, exercise) [24],
area-based characteristics (poverty) and treatment.
Because geographic differences in survival can result from
individuals with similar prognostic factors living in the
same areas (e.g. areas with a high rates of late stage CRC
or areas with high poverty) it is important to adjust for
well known prognostic factors. Such an approach allows
one to determine whether the adjustment factors may be
contributing causes of the survival disparities. In several
studies, geographic disparities in cancer survival persisted
despite adjusting survival time for age and stage at diagno-
sis, two important prognostic factors [21,22].
While previous research has examined a range of determi-
nants of CRC survival, only one study, to our knowledge,
has explored geographic variation [22]. This study
observed several statistically significant areas in California
and Los Angeles County with shorter or longer CRC sur-
vival after adjusting patient survival time for age and strat-
ifying by stage. Black patients were more likely to reside in
the areas with significantly worse survival, and these lower
survival areas were more likely to have high levels of pov-
erty. Additional studies that consider geographic variation
in CRC survival are needed to increase our understanding
of local community influences that may affect a person's
chance of surviving cancer and allow for targeted interven-
tions to population groups at greatest risk of poor out-
comes.
In this study we use a recently developed extension of the
spatial scan statistic for analyzing time-to-event data to
identify whether the survival of CRC patients diagnosed in
New Jersey varies by place of residence after adjusting sur-
vival times for disease and patient factors. We sought to
answer several questions. First, are there areas in New Jer-
sey where CRC survival is significantly longer or shorter
than the statewide experience after adjusting survival
times for significant prognostic factors (sex, age and stage
at diagnosis) and, if yes, what are the approximate loca-
tions of these areas? We specifically adjusted patient sur-
vival times for age and stage at diagnosis in the initial
analysis because we wanted to avoid survival effects result-
ing from statewide geographic variation in these impor-
tant prognostic factors, which have been previously
documented in New Jersey [25]. Second, if significant geo-
graphic differences in CRC survival are detected and we
additionally adjust survival times for race/ethnicity and
area socioeconomic deprivation, do these geographic sur-
vival disparities persist and to what extent are they atten-
uated?
Methods
Data source
CRC cases used for this analysis were obtained from the
New Jersey State Cancer Registry (NJSCR), a population-
based registry that has collected cancer incidence data
since 1979. The NJSCR serves the entire state of New Jer-
sey, which is estimated to have a population of 8.6 mil-
lion people. The NJSCR has reporting agreements with six
other states so that New Jersey residents diagnosed out-
side the state can be identified. The NJSCR is a participant
in the National Cancer Institute's (NCI) Surveillance Epi-
demiology and End Results (SEER) Program which
requires high standards of data quality, as judged by time-
liness, completeness and accuracy.
Study population
Our initial study population consisted of all New Jersey
residents reported to the NJSCR with a histologically con-
firmed, first primary, invasive tumor of the colon or rec-
tum (ICD-O C18.0–C20.9, C26.0, excluding histologies
9590–9989) [26] diagnosed during the period from Janu-
ary 1, 1996 through December 31, 2003 (N = 35,886).
The NJSCR uses NCI SEER summary stage to categorize
the stage at diagnosis for each tumor site. SEER summary
stages at diagnosis are localized to the primary tumor site,
regional by lymph node involvement, regional by lymph
nodes and direct extension, and distant metastases [27].
We excluded CRC cases diagnosed at the distant stage
because in New Jersey the 5-year relative survival rate for
these cases is less than 10% and varies little by race/eth-
nicity and census tract poverty [28,29]. We also excluded
cases with missing stage because a main purpose of this
analysis was to study the effects of adjusting for stage on
colorectal survival. Therefore only cases diagnosed at a
local or regional stage were included. For these patients,
there is a substantial chance of cure with appropriate treat-
ment and patient follow-up; the five-year relative survival
rate is about 79%. The numbers of patients in each stage
group are shown in Table 1.International Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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Analytical Variables
The following individual-level variables known or sus-
pected to be associated with CRC survival were included
in the analysis: age at diagnosis, race/ethnicity group
(non-Hispanic white, non-Hispanic black, Hispanic,
Asian/Pacific Islander), sex (male, female), and stage at
diagnosis (local, regional direct extension, regional lymph
nodes only, regional extension and nodes, regional NOS).
Cases with unknown or other race/ethnicity and those
with an unknown address were excluded. A total of
25,040 cases were used in the analyses (Table 1).
Cases were geocoded to the residential address at time of
diagnosis. Of the geocoded cases, 23,762 (94.8%) were
successfully assigned to census-tracts using the street seg-
ment of the address. We assigned the remaining 1,278
cases (5.2%) to imputed census-tracts based on the postal
delivery area to avoid potential geographic selection bias
resulting from excluding cases not successfully geocoded
[30]. Census tracts were chosen as the units of analysis
because they are small, relatively permanent statistical
subdivisions of a county and are designed to be homoge-
nous with respect to population characteristics, economic
status, and living conditions. New Jersey has 1,951 census
tracts which, on average, contain 4,300 persons.
We selected the 2000 U.S. Census tract poverty rate (the
percentage of population below the poverty line) as the
area-based socioeconomic measure of deprivation [31].
The literature suggests that area-based socioeconomic
characteristics play an important role in affecting a per-
son's health, independent of that person's individual soci-
oeconomic status [9,32-34]. Area-based measures such as
the poverty rate have been shown to capture the discrep-
Table 1: Characteristics of first primary invasive colorectal cancer cases in New Jersey, 1996–2003
Registry Population (N = 35,886) Survival Analysis (N = 25,040)
n% n %
Age (mean) ± SD 69.8 ± 13.2 69.1 ± 13
Gender
Male 17,611 49.1 12,423 49.6
Female 18,275 50.9 12,617 50.4
Race/Ethnicity
Non-Hispanic White (NHW) 29,194 81.4 20,620 82.4
Non-Hispanic Black (NHB) 3,732 10.4 2,464 9.8
Hispanic 2,040 5.7 1,444 5.8
API 720 2.0 512 2.0
Other, Not Specified 200 0.56 0 0.0
SEER Summary Stage
Localized 11,816 32.9 11,308 45.2
Regional, direct extension 6,345 17.7 6,001 24.0
Regional, lymp nodes only 2,882 8.0 2,780 11.1
Regional direct extension and regional lymph nodes 4,848 13.5 4,658 18.6
Regional, Nos 313 0.87 293 1.2
Distant 6,212 17.31 0 0
Missing 3,470 9.7 0 0
Death Certificate Only Cases 397 1.1 0 0
Geocoding level/Census Tract Assignment
Full street address 33,115 92.3 23,881 95.4
Zip code imputed to census tract 1,569 4.4 888 3.6
Zip codes with only one census tract 364 1.0 271 1.1
Not Geocoded/invalid addresss or zip code 838 2.3 0 0
Census Tract Poverty
% Living below poverty
(Low)Q1 (0–3.0) 9087 25.3 6624 26.5
Q2 (3.1–5.5) 10419 29.0 7475 29.9
Q3 (5.6–12) 9217 25.7 6579 26.3
(High)Q4 (>12) 6325 17.6 4362 17.4
Missing Census Tract Poverty 838 2.3 0 0
Source: Data from the New Jersey State Cancer Registry, 2007; U.S. Census Bureau, 2000International Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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ancies in distribution of neighborhood social and eco-
nomic conditions that affect residents[34,35]. Despite the
presence of many single and composite deprivation meas-
ures, we specifically chose poverty because several studies,
including those completed using New Jersey cancer regis-
try data, [25,29] have found census-tract poverty to be a
useful measure of economic deprivation of area-based
socioeconomic variations in cancer incidence, survival
and other health outcomes [34,36,37]. The census tract
poverty measure was grouped into quartiles (Q1 (0–3.0),
Q2 (>3.0–5.5), Q3 (>5.5–12), Q4 (>12.0)) based on the
statewide census-tract distribution of this measure.
Patient Follow-up
The NJSCR conducts passive and active follow-up of can-
cer patients for vital status using linkages with state and
national death files, state taxation files, hospital discharge
files, Medicare and Medicaid files, Social Security Admin-
istration Services for Epidemiologic Researchers, motor
vehicle registration records, and by contacting hospitals
and physicians' offices. Patients were followed until their
death or until December 31, 2006, which is also the date
of censoring for patients who were last known to be alive.
Completeness of vital status follow-up for CRC cases
through December 31, 2006 is around 96%. We excluded
496 cases with no follow-up time. Over 80% percent of
these cases included cases reported from death certificates
where the date of diagnosis and date of death were the
same. Underlying cause of death was abstracted from
death certificates, and identified as due to colon or rectal
cancer according to the International Classification of Dis-
eases (1996–1998 (ICD-9) 153.0–154.1, 159 and 1999–
2003 (ICD-10) C18–C20, C26).
Statistical analyses
We used cancer (cause) specific survival as our primary
measure of patient survival. Cancer-specific survival (or
equivalently cause-specific mortality) is a net survival
measure representing survival of a specified underlying
cause in the absence of other causes of death [38]. This
measure is based on the assumption that deaths from a
specified cause are independent of deaths from other
causes. It has been shown to be a useful measure for can-
cer control when comparing cancer survival between
racial/ethnic or socioeconomic groups or between geo-
graphic areas where death due to other causes may differ;
the NCI refers to this measure as a "policy based statistic"
[9,22,38-42]. Cancer-specific survival is also consistent
with population-based cancer mortality rates, which are
also based on the underlying cause of death.
We specified CRC as the underlying cause of death for this
analysis. Patient survival times were measured in months
from the date of diagnosis and were censored at the date
of death from causes other than CRC, the date a patient is
lost to follow-up or at the end of the follow-up period,
December 31, 2006 (whichever occurred first). The Kap-
lan-Meier estimator was used to estimate CRC-specific
survival rates for race/ethnicity, sex, and poverty quartiles
by stage at diagnosis, and each were compared with the
log-rank test. Five-year CRC-specific survival rates and
associated 95% confidence intervals (CI) were also com-
puted based on Kaplan-Meier survival curves.
Geographical Analyses
We applied the exponential model based spatial scan sta-
tistic using SaTScan software (v.7.02) to determine
whether there is geographic variation in CRC survival
without any a priori assumptions regarding the location
or size of possible variation [43,44]. Survival time was
modeled using an exponential probability distribution,
comparing the mean survival times of patients in a geo-
graphical area (θin) with that of patients outside that area
(θout). The entire study region is examined for significant
deviation in survival by using a circular scanning window
that varies in size from 2 cases to a maximum of 50% of
the cases. We choose a circular scanning window because
this shape has been shown to be effective at highlighting
general areas or regions of concern. For each circular win-
dow the maximum likelihood method was used to test for
deviations from the null hypothesis that the mean CRC
survival time of cases inside and outside the scanning win-
dow are equal (Ho: θin =θout; Ha:θin ≠ θout). Finally, a
Monte Carlo permutation was used to evaluate statistical
significance and adjust for multiple testing by permuting
survival time and censoring indicators among locations. A
more thorough review of the exponential based spatial
scan statistic and the permutation test can be found else-
where [45].
Before applying the spatial scan statistic to search for areas
with short or long survival, CRC patient survival times
were adjusted for covariates using three separate fixed
effects exponential regression models. The three models
included the following covariates: (1) sex, age, and stage
at diagnosis; (2) sex, age, stage at diagnosis, and race/eth-
nicity; (3) sex, age, stage at diagnosis, race/ethnicity, and
census-tract poverty quintiles. The adjustment produces
expected survival times based on the specified explanatory
factors. Details of such adjustments have been described
elsewhere [22,45].
Spatial scan statistic analysis was conducted separately for
each of the adjusted survival time datasets, as described
above. We identified all statistically significant (p =< 0.05)
areas (circles) with shorter or longer than expected sur-
vival regardless of scanning window location or size and
mapped the results using a nested circle approach pro-
posed by Boscoe et al. (2003), which is summarized as
follows. First, the survival areas detected were stratifiedInternational Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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into equal intervals of risk (observed/expected CRC
deaths). Within each risk interval, the area with the high-
est likelihood ratio (lowest p value) was mapped. Areas
with lower likelihood ratios were also mapped if they did
not overlap any previously mapped area within the same
risk interval. Mapping was completed using ArcGIS 9.3
software [46].
For areas with statistically significant shorter or longer sur-
vival, we reported the total cases, observed deaths, ratio of
observed/expected CRC deaths (obs/exp) as defined by
SaTscan, the percent of cases by race/ethnicity, and the
average percent of census-tract poverty among the cases.
The expected CRC deaths were based on a comparison of
individual time (either survival time or censoring time)
with the mean survival time – if the observed individual
time was smaller than the mean survival time, it was con-
sidered a death. We also reported adjusted 5-year survival
rates and 95% confidence intervals (CI) inside and out-
side each of the detected survival areas using a method by
Zhang et al. (2007) which uses Cox regression estimates
to adjust survival for selected covariates. Adjusted survival
time and 5-year survival rates were calculated using SAS,
version 9.1[47]
Results
Descriptive Analyses
Table 1 describes the overall population of CRC cases
reported to the NJSCR from 1996 through 2003, as well as
the population subset used for the study. Among the cases
used in the study 82.4% were non-Hispanic white, 9.8%
were non-Hispanic black, 5.8% were Hispanic and 2.0%
were Asian Pacific Islander (API). Cases ranged in age
from 18 to 101 with an average age of 69. Approximately
45% of the cases were diagnosed at the local stage and
55% at the regional stage.
Among the 25,040 cases included in the study, 4,858 died
from CRC and 20,182 cases were right censored (1,327
lost to follow-up; 6,070 non-CRC deaths; 12,785 alive at
the end of follow-up [December 31, 2006]). Characteris-
tics of the local and regional stage CRC cancer cases used
for the analyses are presented in Table 2. The five-year
CRC-specific survival rate was 90.7% for local stage cases,
70.4% for regional stage cases, 79.6% overall. Race/eth-
nicity effects on survival were statistically significant (log-
rank P < 0.001). The five-year survival rate was 83.2% in
non-Hispanic whites, the highest among all racial/ethnic
groups, compared with the lowest 75.6% in blacks. Area
poverty gradients were observed in survival rates for both
local and regional cases and the effects were statistically
significant (log-rank P < 0.001).
Geographic Analyses
In the geographic analyses, several regions of New Jersey
showed statistically significant differences in CRC sur-
vival. Table 3 describes the survival characteristics of the
areas having significantly shorter or longer survival from
Table 2: Colorectal cancer case characteristics and 5-year survival of localized and regional cases used in the analyses by sex, race/
ethnicity, census tract poverty and mean age at diagnosis (1996–2003)
Study Population 5-Year
Survival (95%CI)
Localized Cases 5-Year
Survival (95%CI)
% Cases Regional Cases 5-Year
Survival (95%CI)
% Cases
n = 25,040 n = 11,308 n = 13,732
Total population 79.6 (79.1, 80.2) 90.7 (90.1, 91.2) 45.2 70.4 (69.5, 71.2) 54.8
Sex
Male 80.2 (79.5, 81.0) 90.9 (90.0, 91.7) 45.9 71.1 (69.8, 72.7) 54.1
Female 79.0 (78.2, 79.4) 90.4 (89.6, 91.2) 44.4 69.8 (68.6, 71.0) 55.6
P value from Log-rank 0.01 0.79 0.03
Race/Ethnicity
Non-Hispanic White 83.2 (79.6, 86.9) 92.2 (87.9, 96.5) 45.5 77.6 (72.4, 82.8) 54.5
Non-Hispanic Black 75.6 (73.9, 77.6) 87.6 (85.4, 89.7) 45.1 65.7 (62.9, 68.6) 55.0
Hispanic 79.1 (76.8, 81.4) 90.1 (87.6, 92.6) 43.7 70.5 (67.1, 74.0) 56.2
API 80.0 (79.4, 80.6) 91.0 (90.3, 91.6) 37.1 70.7 (69.8, 71.7) 62.9
P value from Log-rank <0.0001 0.009 0.0002
Census Tract Poverty, % Living 
below poverty
(Low)Q1 (0–3.0) 81.8 (80.8, 82.8) 92.2 (91.2, 93.2) 45.2 73.2 (71.7, 74.8) 54.8
Q2 (3.1–5.5) 80.9 (80.0, 81.9) 91.8 (90.8, 92.8) 45.6 71.6 (70.1, 73.1) 54.4
Q3 (5.6–12) 78.9 (77.8, 80.0) 89.4 (88.2, 90.6) 45.4 70.0 (68.4, 71.6) 54.6
(High)Q4 (>12) 74.9 (73.4, 76.3) 87.9 (86.3, 89.5) 44.0 64.4 (62.3, 66.6) 56.0
P value from Log-rank <0.0001 <0.0001 <0.0001
Source: Data from the New Jersey State Cancer Registry, 2007; U.S. Census Bureau, 2000; CI = Confidence Interval API = Asian Pacific Islander
5-year colorectal cancer specific survival rates based on Kaplan-Meier estimates
Numbers indicate median values for each poverty quintileInternational Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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each of the models. Figure 1 illustrates the survival loca-
tions and related ratios of observed to expected CRC
deaths.
Statistically significant departures from the statewide rates
occurred only in the northern part of the state. Longer
than expected survival in areas A and B (suburbs of Morris
and Somerset counties) and in areas C and D (a densely
populated portion of Bergen County) correspond to pre-
dominantly high-income white neighborhoods (Figure
1a). Residents of these areas had a lower-than-expected
risk of CRC death than elsewhere (O/E = 0.72, 0.54, 0.75,
0.67 for A, B, C, D, respectively, with p-values < 0.05); and
the adjusted 5-year survival rates ranged in these areas
from 88.3% to 83.6%, several percentage points higher
than elsewhere (approximately 80%) (Table 3a).
Shorter survival times were estimated among cases in
areas E, F and G, nested in the north central part of the
state. The worst outcomes were found in area G, in the cit-
ies of Newark, Elizabeth, and East Orange (Essex County)
and Union and Jersey City (Hudson County), predomi-
nantly low-income black and Hispanic neighborhoods
(Figure 1a). The risk of dying from CRC among persons
living in area G was estimated 1.4 times greater than else-
where (p < 0.001), and the area had a 73.1% survival rate
compared with 80% elsewhere in the state (Figure 1a).
Additional adjustment of survival times for race/ethnicity
resulted in several areas becoming non-significant and
three new areas, all of which overlap previously defined
areas – H and I are attenuated versions of areas F and G,
and J is an elevated version of part of area F (Table 3b).
Area B remained the only area with significantly longer
than expected survival. Of the newly defined areas with
shorter than expected survival, area J, located partially in
Passaic City, a relatively low income and largely white and
Hispanic area, had the worst survival (Figure 1b). The risk
of dying from CRC in this area was estimated to be 1.6
times greater than among the other cases in the state
(Table 2). The adjusted 5-year survival rate was 71.4%
(95% CI 61.1, 75.7) compared with 79.3% (95% CI 78.9,
80.0) elsewhere.
After additional adjustment of survival times for census-
tract poverty, several more areas became non-significant,
Areas with statistically significant shorter or longer than expected survival following diagnosis of colorectal cancer adjusted for:  (1) sex, age, stage at diagnosis (2) sex, age, stage at diagnosis, race/ethnicity (3) sex, age, stage at diagnosis, race/ethnicity, cen- sus tract poverty Figure 1
Areas with statistically significant shorter or longer than expected survival following diagnosis of colorectal 
cancer adjusted for: (1) sex, age, stage at diagnosis (2) sex, age, stage at diagnosis, race/ethnicity (3) sex, age, 
stage at diagnosis, race/ethnicity, census tract poverty. Area characteristics are summarized in Table 3.I
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Table 3: Case characteristics and adjusted 5-year survival rates for areas with shorter or longer than expected survival as defined by the spatial scan statistic.
Survival time 
adjusted for:
Study Areaa Total Cases Obs deaths O/E deaths P-value AVG % CT
Povertyb
% NHW % NHB % H % A Adjusted 5-year
survivalb (95% CI)
inside survival
aread
Adjusted 5-year
survivalc (95% CI)
outside survival
aread
a. Age, sex, stage
A 1,252 188 0.72 0.040 3.4 91.1 2.2 3.8 2.9 84.2
(82.1, 86.3)
78.9
(78.4, 79.5)
B 486 61 0.54 0.010 3.2 91.6 3.3 1.9 3.3 88.3
(85.4, 91.3)
79.1
(78.5, 79.5)
C 1,713 271 0.75 0.047 5.9 82.6 5.3 6.8 5.4 83.6
(81.8, 85.5)
78.9
(78.3, 79.5)
D 954 133 0.67 0.043 4.4 80.7 8.2 6.2 4.9 85.6
(83.2, 88.0)
79.0
(78.4, 79.5)
E 10,113 2,124 1.10 0.008 9.3 73.6 14.4 9.8 2.3 77.5
(76.7, 78.3)
80.4
(79.7, 81.1)
F 5,804 1,324 1.24 <0.001 12.2 65.5 19.5 12.9 2.1 75.2
(74.0, 76.3)
80.4
(79.8, 81.0)
G 2,771 666 1.40 <0.001 17.8 50.1 27.7 19.8 2.4 73.1
(71.5, 74.9)
80.0
(79.4, 80.5)
b. Age, sex, stage, 
race/ethnicity
A 1,252 188 0.74 0.424 83.7
(81.5, 85.9)
78.9
(78.4, 79.5)
B 486 61 0.56 0.048 87.9
(84.9, 90.9)
79.0
(78.5, 79.5)
C 1,713 271 0.76 0.164 83.3
(81.5, 85.2)
78.9
(78.3, 79.4)
D 954 133 0.68 0.093 85.4
(83.1, 87.8)
78.9
(78.4, 79.5)
E 10,113 2124 1.07 0.809 77.9
(76.9, 78.6)
80.1
(79.5, 80.8)
F 5,804 1324 1.17 <0.001 76.0
(74.5, 76.9)
80.2
(79.6, 80.8)
G 2,771 666 1.25 0.002 74.5
(72.4, 76.0)
79.8
(79.2, 80.3)
H 5,772 1,315 1.18 <0.001 12.2 65.5 19.5 12.9 2.1 75.7
(74.6, 76.9)
80.4
(79.8, 81.0)
I 4,621 1,072 1.20 <0.001 12.9 63.6 21.3 12.9 2.2 75.4
(74.1, 76.7)
80.2
(79.7, 80.8)
J 386 125 1.63 0.037 16.3 57.5 23.3 18.1 1.0 71.4
(67.1, 75.7)
79.3
(78.9, 80.0)I
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c. Age, sex, stage, 
race/ethnicity, CT 
poverty
A 1,252 188 0.78 0.987 83.0
(80.8, 85.3)
79.0
(78.4, 79.5)
B 486 61.0 0.60 0.398 87.3
(84.2, 90.5)
79.0
(78.5, 79.5)
C 1,713 271 0.78 0.495 83.1
(81.3, 85.0)
78.9
(78.3, 79.4)
D 954 133 0.72 0.701 84.8
(82.3, 87.3)
78.9
(78.4, 79.5)
E 10,113 2124 1.06 0.987 77.9
(77.1, 78.8)
80.0
(79.3, 80.7)
F 5,804 1324 1.12 0.132 76.3
(75.2, 77.5)
80.0
(79.5, 80.6)
G 2,771 666 1.13 0.987 75.7
(73.9, 77.5)
79.6
(79.1, 80.2)
H 5,772 1315 1.13 0.107 76.3
(75.0, 77.4)
80.0
(79.4, 80.6)
I 4,621 1072 1.14 0.146 76.2
(74.8, 77.4)
79.9
(79.3, 80.5)
J 386 125 1.54 0.344 72.6
(68.3, 76.8)
79.3
(78.7, 79.8)
K 5,404 1,224 1.15 0.017 11.3 67.2 20.7 9.9 2.2 76.2
(75.0, 77.4)
80.3
(79.7, 81.0)
L 1,316 327 1.32 0.048 8.1 78.9 11.1 9.0 1.1 74.6
(72.2, 76.9)
79.5
(79.0, 80.0)
Geographic locations illustrated in figure 1.
a Short or long survival areas detected by the spatial scan statistic are illustrated in Figure 1.
b Averages for each area are based on the census tract values assigned to the cases.
c Directly adjusted 5 year colorectal cancer specific survival rates are based on a Cox regression model adjusted for specified covariates. The method adjusts survival time by covariates to adjust 
for any imbalance of CRC case characteristics inside and outside defined survival area (e.g All CRC cases inside area A versus all CRC cases outside area A).
d Inside refers to the adjusted survival time of all CRC cases inside the specified survival area (e.g Cases inside detected area A). Outside refers to the adjusted survival time of all CRC cases 
outside the specified survival area (e.g. Cases outside detected area A).
P-value from spatial scan statistic Monte Carlo permutation test.
Table 3: Case characteristics and adjusted 5-year survival rates for areas with shorter or longer than expected survival as defined by the spatial scan statistic. (Continued)International Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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and the risk of dying from CRC was further reduced in
areas previously detected with shorter survival (Table 3c).
No significantly longer than expected survival areas
remained. Two remaining areas with significantly shorter
than expected survival (K and L) were located in the same
region as the previously defined areas (O/E = 1.2 and 1.3
for K and L, respectively) (Figure 1c).
Discussion
Our findings suggest that survival of CRC patients diag-
nosed in New Jersey varies by place of residence after
adjusting for disease and patient characteristics. Geo-
graphic analysis based on age and stage adjusted survival
times detected several areas in the northern part of the
state where CRC survival outcomes were significantly dif-
ferent than expected. Survival disparities persisted in some
areas even after adjusting patient survival times for race/
ethnicity and area socioeconomic deprivation, as defined
by census-tract poverty.
Regional demographics and patient characteristics pro-
vide some evidence that the initial results based on age-
stage adjusted survival might reflect geographical concen-
trations of patients who can be presumed at greater or less
risk of poor outcomes regardless of age and stage at diag-
nosis – blacks and persons living in poor areas may be at
greater risk of poor outcomes compared with whites and
persons living in wealthy areas (Table 3)[29,40,48,49].
Areas detected with the best survival, for example, were
found in predominately high income white neighbor-
hoods in Morris, Somerset and Bergen counties; whereas
areas with the worst survival were found in mostly low
income, racially diverse neighborhoods in several large
cities in Essex and Union counties. There are numerous
characteristics of poor neighborhoods that could impede
patient survival such as high unemployment, poor educa-
tion, health impairing environmental exposures, sub-
standard housing and limited access to resources and
information.
Our age-stage adjusted survival estimates were consistent
with findings of Huang et al. (2007) who completed a
similar study using CRC data from California. They found
several statistically significant areas in Los Angeles (LA)
County with shorter or longer CRC survival after adjusting
patient survival time by age and stratifying by stage. The
shorter survival areas in LA County, like those detected for
New Jersey, had both a higher percent of black cases and
a higher percent of cases living in impoverished areas than
the longer survival areas. In another study that used simi-
lar methods, but analyzed prostate cancer survival, Grego-
rio et al. (2007) also noted significant geographic
variation after applying age-stage adjusted survival times.
Adjustment for patient's race/ethnicity and area socioeco-
nomic deprivation further reduced survival disparities for
several areas, but two areas remained significant with
worse-than-expected outcomes. These results suggest race/
ethnicity and area socioeconomic deprivation does affect
outcomes in some locations in New Jersey, while one area
in particular remains unexplained. Further research is
needed to identify the causal factors that mediate this rela-
tionship.
It is unclear why areas of worse than expected CRC sur-
vival remain unexplained after adjusting for area socioe-
conomic deprivation. Possibilities include a local
problem of access to health care or a pattern of care at one
or more hospitals. Such patterns have been documented
in the Dartmouth Atlas of Health Care project [50]. For
stage III colon cancer, Etzioni et al. (2008) found that the
likelihood of receipt of chemotherapy was influenced by
referral patterns, hospital volume, and the presence of a
cancer program approved by the American College of Sur-
geons' Commission on Cancer [51]. There may be other
individual factors that contribute to these survival differ-
ences. For example, it could be related to modifiable risk
factors (e.g smoking, diet, exercise) or comorbidity that
are often themselves geographically structured [24]. Also
since these areas are ethnically diverse, with substantial
immigrant populations; it is possible that language barri-
ers may affect access or coordination of care [52]. It is also
possible that the adjustments for race/ethnicity and socio-
economic deprivation are inadequate or incomplete.
We have identified significantly divergent areas of CRC
survival in New Jersey after adjusting for important prog-
nostic factors, including age and stage at diagnosis. The
next focus of investigation could be comparing their dif-
ferences in comorbidity status as well as medical care in
terms of access, utilization and quality. Such analysis
could be completed for persons 65 years and older using
the SEER-Medicare linked database which includes regis-
try data and Medicare claims for covered health care serv-
ices, including hospitalizations. Schootman et al. (2009)
used this database to examine geographic patterns of
breast cancer survival in several geographic areas[23]. It
would also be important to examine other determinants
of CRC risk and survivorship such as diet and exercise.
Interviewing cancer survivors in these locations about
their experiences combined with medical chart reviews
may lead to clarification of groups at greatest risk of dying
from CRC and provide explanations to geographical pat-
terns of CRC survival. Perhaps future analysis might reveal
that areas with longer than expected survival may high-
light protective effects such as social support and/or clini-
cal advancements that warrant replication in other places.
Applying the spatial scan statistic as we did in this study to
adjusted survival times allows a better understanding of
the extent to which geographic patterns of CRC survival
can be explained by important risk factors. DocumentingInternational Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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risk of death (observed vs expected) by geographic area
after each covariate adjustment and tracking changes in
risk provides a useful approach, analogous to the methods
used in non-spatial statistics (e.g., Cox regression). While
traditional non-spatial analysis provides greater clarity as
to the precise contribution of each risk factor, this comple-
mentary approach has the advantage of highlighting spe-
cific geographic locations.
Using the 'nested circles' approach to map areas detected
from the spatial scan statistic provides a greater degree of
information about the risk of death from CRC among sig-
nificant localized excess contained within a broader
region of deficit. Typically, studies using the spatial scan
statistic document only the areas that are significant, have
the highest likelihood ratios, and do not overlap. As
Boscoe et al. explain, this approach tends to identify large
geographic areas with large populations, but small eleva-
tions in risk because these areas have the highest statistical
power[53]. Changing the maximum scanning window
size in the software can control for this, but the optimal
size is not obvious. Also, selecting the final maximum
window size on previous analyses can lead to pre-selec-
tion bias. In our study, areas E and D would have been the
only areas detected if we followed typical practice and set
the scanning window to a maximum of 50% of the cases
and did not allow for geographic overlap. This has impor-
tant public health implications if the areas detected will
be used for targeted intervention.
For cancer control and prevention activities it is also
important to acknowledge two further caveats related to
the interpretation of our results. First, the significantly bet-
ter or worse survival areas detected in our study may not
be circular and are based on an identification procedure
that relies on circular scanning windows. While circles are
effective at highlighting general areas or regions of con-
cern the boundaries of these areas are always approxi-
mate. Other shapes could have been employed (e.g.
elliptical) and this would have likely resulted in some-
what different boundaries. Second, it is also important to
consider the variation within the detected clusters and to
remember that risk within these areas may not be evenly
distributed. Future work using the spatial scan statistic
should consider displaying maps of smoothed survival
rates (descriptive or model based) beneath the statistically
significant clusters [54]. Doing so would provide addi-
tional information that could be helpful to assist with the
generation of hypotheses about underlying causes of sur-
vival disparities. Approaches for mapping geographic var-
iation of patient survival have been demonstrated by
Banerjee et al. (2003) and Lawson [55,56].
The results of this study need to be evaluated in light of a
number of important limitations. First, by using CRC-spe-
cific survival we are presuming accuracy of the underlying
cause of death on death certificates [57]. The extent to
which misclassification of underlying cause of death
occurred and the impact it had on our findings cannot be
determined. It has been reported, however, that when
deaths from colon cancer or rectum cancer are combined
the accuracy of coding CRC as an underlying cause of
death on death certificates is around 93 percent [58].
However, little is known about whether the accuracy of
cause of death on death certificates varies by geography.
Another limitation is related to our inability to assess
competing risks. Competing risks occur when there are at
least two possible ways a patient can die (patients in our
study could die from CRC or some other cause). When
using cause-specific survival the assumption is deaths
from a specified cause (e.g. CRC) are independent of
deaths from other causes – thus we are assuming the
absence of competing risks. If the independence assump-
tion is not met, a bias could result because cases who are
censored are more likely to die than non-censored cases
[59,60] The main reason we could not assess competing
risks was because we did not have comorbidity informa-
tion or individual risk factors (e.g smoking). Instead we
conducted sensitivity analyses of our geographic results
using the following censoring scenarios: [60] (1) all
patients previously censored because of deaths from other
causes are assumed to die of CRC (all cause-survival); (2)
all patients previously censored because of deaths from
other causes survive to the end of follow-up (December
31, 2006); (3) a randomly selected subset of 5% (or 10%,
20%, 30%, 40%, 50%) of patients previously censored
because of deaths from other causes are assumed to die of
CRC. These scenarios allow us to consider what Klein-
baum and Klein refer to as "worst-case violations of the
independence assumption" [60]. For each scenario, we
detected survival disparities in approximately the same
locations as the CRC-specific analysis; however scenario
(1) detected a significant area of shorter than expected sur-
vival in the southwestern part of the state. Similarities
between the different censoring scenarios and our results
suggest minimal bias related to the independence
assumption.
A third potential limitation is the geographic distribution
of cases censored because they were lost to follow-up (e.g.
migration). While there were more cases lost to follow-up
inside the shorter and longer survival areas compared to
outside each of these areas, the differences were minimal
(the maximum difference was around 2 percent) and
would likely have nominal impact on our findings. Also a
review of the proportion of cases censored because of
non-CRC deaths inside and outside the shorter survival
areas deaths indicated no significant differences.International Journal of Health Geographics 2009, 8:48 http://www.ij-healthgeographics.com/content/8/1/48
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Further limitations include a lack of important patient
information available from the NJSCR. For example,
incomplete CRC treatment data at the NJSCR limited our
ability to use this information to determine its impact on
survival differences. Furthermore, the NJSCR only collects
information on first course of treatment. Patient insur-
ance data was not included because it was only required
by the NJSCR starting in 1999. And the NJSCR and the
SEER programs do not collect information about co-mor-
bidity or lifestyle risk factors that may be associated with
cancer incidence and prognosis (e.g. obesity, smoking,
diet, and alcohol).
One additional caveat concerns how missing data
excluded from our study may bias our findings [61,62].
Cancer registry data is often not missing at random, but
varies by age, race/ethnicity, socioeconomic status and
geography[63,64]. Among cases excluded due to incom-
plete geocoding (2%) there were no statistically signifi-
cant differences by race/ethnicity, but these cases were
more likely to be older than 75 years of age and missing
stage information. Because there were so few cases with
incomplete geocoding it is unlikely to have influenced our
results. The greatest number of cases excluded were due to
missing stage of disease at diagnosis (approximately
9.6%). Cases typically lack stage information due to med-
ical decisions, lack of information in the medical record
due to a superficial workup, or because they were
obtained from death certificates only (DCO). Stage which
is a proxy for prognosis is often missing in population
based registries which, not only make the geographic pic-
ture incomplete, but may introduce bias [63]. Treatment
information as well as information on stage is related to
socioeconomic status [65], and missing stage has been
shown to be higher among blacks than whites in central
cancer registry data [64]. In our study we found statisti-
cally significant differences among cases without stage
information by race/ethnicity (Whites, 9.3% versus
blacks, 10.8%), age at diagnosis (<75, 8.6% versus >75,
17.8%) and area poverty (Low poverty, 9% versus high
poverty 10.8%). Survival estimates for cases missing stage
were more similar to regional stage disease than local or
distant stage disease. Because the profile of cases missing
stage were more similar to those at greatest risk of dying
from CRC, our survival estimates could be slightly con-
servative if a substantial number of the cases were local or
regional stage and were geographically distributed non-
randomly.
Despite several potential limitations, this study is
strengthened by the use of histologically confirmed CRC
cases followed for up to 10 years from a large population-
based SEER cancer registry with a large population (8.7
million people) and socioeconomic and racial diversity.
Further strengths are high quality geocoding and the com-
pleteness of patient vital status follow-up (95.5%) since
the NJSCR uses both active and passive methods.
Conclusion
In summary, we observed significant differences in age
and stage at diagnosis adjusted survival by geographic
location among the over 25,000 residents of New Jersey
diagnosed with localized or regional stage CRC from 1996
through 2003. Further adjustment for race/ethnicity and
area poverty reduced geographic survival disparities but
did not completely explain them. These findings suggest
that, in areas where adjustment changed the geographic
survival patterns and reduced the risk of death, these fac-
tors may be contributing causes of the disparities. Con-
versely, geographic disparities that persist after
adjustment likely indicate areas of unexplained, and
potentially amendable, variation. Further studies need to
focus on identifying specific pathways by which local fac-
tors and area socioeconomic deprivation explain geo-
graphic survival disparities.
Our use of the recently developed exponential based spa-
tial scan statistic to examine geographic variation in CRC
survival demonstrates how researchers and public health
practitioners can apply this method to monitor cancer sur-
vival disparities, evaluate the effectiveness of statewide or
locally based interventions and generate hypotheses
about the underlying causes of geographic disparities in
cancer survival. To our knowledge the exponential based
statistic has only been applied to cancer survival data, but
its usefulness for analyzing time-to-event makes it suitable
for other applications including disease remission, cure or
cessation of behavior, or hospital discharge time.
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